Sildenafil Citrate Tablet, Film Coated
Product Images NDC 50090-5906

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Sildenafil Citrate (NDC 50090-5906). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Sildenafil_fig1.jpg (Sildenafil Fig1)

A line graph showing mean change from baseline in sitting systolic blood pressure over 24 hours for healthy volunteers. The x-axis represents time post dose in hours, and the y-axis shows systolic blood pressure in mmHg. Two lines depict responses to Sildenafil 100 mg and placebo treatments.*

FDA Label Image

Sildenafil_fig3 (Sildenafil Fig 3)

A line graph titled 'Mean Standing Systolic Blood Pressure Change from Baseline' showing blood pressure change (mmHg) over time postdose (hours) for two groups: Doxazosin + Placebo and Doxazosin + Sildenafil 50 mg. The graph compares the effects of these treatments on systolic blood pressure from 0 to 8 hours postdose.*

FDA Label Image

Sildenafil_fig_4 (Sildenafil Fig 4)

A line graph titled 'Mean Standing Systolic Blood Pressure Change from Baseline' showing changes over 8 hours after dosing. Two curves compare Doxazosin with Sildenafil 100 mg and Doxazosin with placebo, with blood pressure changes on the vertical axis (mmHg) and time in hours on the horizontal axis.*

FDA Label Image

Sidenafil_fig_5 (Sildenafil Fig 5)

Figure 5 shows a graph of mean sildenafil plasma concentrations in healthy male volunteers over 24 hours after dosing. The y-axis represents plasma concentration in ng/ml, peaking shortly after administration, while the x-axis shows time post dose in hours. The curve depicts concentration decline over time after a commercial tablet dose.*

FDA Label Image

Label Image (Lbl500905906)

Sildenafil Citrate 25 mg film-coated tablets packaging label from A-S Medication Solutions. The label indicates 10 tablets per package, with storage instructions to store at 77 degrees Fahrenheit. It includes the product number, NDC 50090-5906-0, and states the dosage form as tablet, film-coated, containing sildenafil citrate equivalent to 25 mg sildenafil.*

FDA Label Image

Sildenafil-fig7 (Sildenafil Fig7)

A bar chart showing the percentage of patients reporting improvement across four treatment groups: placebo (24%), Sildenafil Tablets 25 mg (63%), Sildenafil Tablets 50 mg (74%), and Sildenafil Tablets 100 mg (82%). The x-axis lists treatment groups with patient counts, and the y-axis represents percentage improvement.*

FDA Label Image

Str (Sildenafil Structure)

Chemical structure of Sildenafil Citrate, showing the arrangement of atoms in this active pharmaceutical ingredient used for oral tablets.*

FDA Label Image

Figure2 (Sildenafil Fig2)

A line graph showing changes in EDP (mmHg) over time (hours) for two treatments: Doxazosin with placebo and Doxazosin with Sildenafil 25 mg. The x-axis represents time postdose up to 8 hours, and the y-axis represents the change in EDP with values ranging roughly from -40 to +20 mmHg. Two distinct lines compare the effects of the two treatments over the time course.*

FDA Label Image

Sildenafil_fig6b (Sildenafil Fig6b)

A bar chart depicting the percentage of patients at endpoint across different baseline scores ranging from 0 to 5. The y-axis represents the percentage of patients, while the x-axis shows baseline scores. Multiple data series are differentiated by varying bar colors or patterns, with a legend indicating six distinct categories.*

FDA Label Image

Sildenafil_fig6a (Sildenafil Figure6a)

A bar chart illustrating the percentage of patients at endpoint categorized by baseline score. The x-axis represents baseline scores from 0 to 5, and the y-axis shows the percentage of patients. Different bars with various shading patterns represent different groups or conditions, as indicated by the legend on the right.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.